BAT(BTI) - 2025 H1 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Group revenue increased by 1.8%, adjusted gross profit rose by 3%, and adjusted profit from operations grew by 1.9%, with adjusted diluted EPS increasing by 1.7% [10][24][47] - The company anticipates full-year revenue at the top end of the 1% to 2% guidance, maintaining APFO guidance of 1.5% to 2.5% [10][26] Business Line Data and Key Metrics Changes - Smokeless products now account for 18.2% of Group revenue, up 70 basis points from last year, with 1.4 million new smokeless consumers added [4] - New categories revenue increased by 2.4%, driven by modern oral growth of over 40% and heated products rising by more than 3%, while vapor declined by 13% [11][12] - Combustibles revenue increased by 0.8%, with volume decline offset by strong pricing, leading to a gross profit increase of 2.4% [13][14] Market Data and Key Metrics Changes - In the U.S., revenue grew by 3.7%, with combustibles driving the growth, while modern oral revenue increased by 3.9% [16][17] - The AME region saw revenue rise by 3.5%, with combustibles up nearly 3% due to strong volumes in Brazil and Turkey [17] - APMEA experienced a total revenue decline of 4.8%, with combustibles down 7.9%, impacted by regulatory headwinds in Bangladesh and Australia [19][20] Company Strategy and Development Direction - The company is focused on a multi-category strategy to leverage consumer trends towards new categories, with significant investments in modern oral and heated products [28][30] - The introduction of the "Fit to Win" program aims to simplify operations and enhance digital decision-making, targeting £500 million in annualized savings by 2028 [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to revenue and profit growth in the U.S., highlighting the importance of regulatory affairs and enforcement for smokeless alternatives [6][41] - The company remains optimistic about the long-term growth potential of modern oral products, especially in emerging markets [30][31] Other Important Information - The company has increased its 2025 share buyback program by £200 million to £1.1 billion, reflecting strong cash generation and commitment to shareholder returns [4][25] - The company has delivered nearly £900 million in productivity savings since 2023 and aims to exceed £1.2 billion by year-end [21] Q&A Session Summary Question: Can you discuss the early performance of GloHilo in Japan and its rollout plans? - Management reported positive feedback from Japanese consumers, with a tailored product offering leading to early market share gains. The rollout will focus on high-profit pools through the end of the year [52][54] Question: What is the current momentum for VeloPlus in the U.S.? - VeloPlus is maintaining strong momentum with high retention rates and increasing market share, despite competitive pressures [57][58] Question: Can you clarify the Fit to Win program's costs and savings? - The program will have some costs in 2025, with a target of £500 million in annualized savings by 2028, which will be reinvested into growth initiatives [61][62] Question: What is the outlook for the vape business in the AME region? - The vape business is facing challenges in Canada due to regulations, but there is potential for growth as the market transitions to closed systems [66][70] Question: How is the company addressing the illegal vapor market in the U.S.? - Management noted a 40% reduction in illegal vapor shipments, with ongoing efforts to enforce regulations and improve market conditions [74][76] Question: What is the impact of the duty drawback on U.S. business? - The duty drawback is positively impacting the top line, but the company is also seeing growth from improved market share and pricing strategies [97][100] Question: Is there capacity to meet the expected growth in VeloPlus? - The company is well-equipped to handle the growth in VeloPlus, with no anticipated capacity shortages [102]